# Village Farms International, Inc.: financial statements, quarterly

VFF · Nasdaq · CIK 1584549 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vff.md) · [Financials](/companies/vff/financials.md) · [Filings](/companies/vff/filings.md) · [Insiders](/companies/vff/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vff/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [69.5](/filings/0000950170-24-122773.md) | [(48.3) d](/filings/0001193125-26-104189.md) | [78.1](/filings/0000950170-25-069458.md) | [53.6](/filings/0000950170-25-106223.md) | [54.9](/filings/0001193125-25-273223.md) | [45.4 d](/filings/0001193125-26-104189.md) | [39.7](/filings/0001193125-26-215665.md) | [59.9](/filings/0001193125-26-341194.md) | [66.7](/filings/0001193125-25-273223.md) | [49.6 d](/filings/0001193125-26-104189.md) | [50.2](/filings/0001193125-26-215665.md) | [64.0](/filings/0001193125-26-341194.md) |
| Cost of revenue | $m | [54.9](/filings/0000950170-24-122773.md) | [(57.8) d](/filings/0001193125-26-104189.md) | [62.6](/filings/0000950170-25-069458.md) | [40.0](/filings/0000950170-25-106223.md) | [41.3](/filings/0001193125-25-273223.md) | [38.1 d](/filings/0001193125-26-104189.md) | [25.5](/filings/0001193125-26-215665.md) | [37.6](/filings/0001193125-26-341194.md) | [34.8](/filings/0001193125-25-273223.md) | [30.4 d](/filings/0001193125-26-104189.md) | [29.3](/filings/0001193125-26-215665.md) | [34.0](/filings/0001193125-26-341194.md) |
| Gross profit | $m | [14.6](/filings/0000950170-24-122773.md) | [9.5 d](/filings/0001193125-26-104189.md) | [15.5](/filings/0000950170-25-069458.md) | [13.6](/filings/0000950170-25-106223.md) | [13.6](/filings/0001193125-25-273223.md) | [7.3 d](/filings/0001193125-26-104189.md) | [14.2](/filings/0001193125-26-215665.md) | [22.3](/filings/0001193125-26-341194.md) | [31.9](/filings/0001193125-25-273223.md) | [19.2 d](/filings/0001193125-26-104189.md) | [21.0](/filings/0001193125-26-215665.md) | [30.0](/filings/0001193125-26-341194.md) |
| Selling, general and administrative | $m | [15.8](/filings/0000950170-24-122773.md) | [6.7 d](/filings/0001193125-26-104189.md) | [16.4](/filings/0000950170-25-069458.md) | [17.1](/filings/0000950170-25-106223.md) | [14.6](/filings/0001193125-25-273223.md) | [15.9 d](/filings/0001193125-26-104189.md) | [14.6](/filings/0001193125-26-215665.md) | [15.4](/filings/0001193125-26-341194.md) | [15.6](/filings/0001193125-25-273223.md) | [14.7 d](/filings/0001193125-26-104189.md) | [15.9](/filings/0001193125-26-215665.md) | [18.8](/filings/0001193125-26-341194.md) |
| Operating income | $m | [0.8](/filings/0000950170-24-122773.md) | not reported | not reported | not reported | [2.1](/filings/0000950170-24-122773.md) | not reported | [(0.4)](/filings/0001193125-26-215665.md) | [6.9](/filings/0001193125-26-341194.md) | not reported | not reported | [5.0](/filings/0001193125-26-215665.md) | [11.2](/filings/0001193125-26-341194.md) |
| Interest expense | $m | [1.0](/filings/0000950170-24-122773.md) | [1.0 d](/filings/0001193125-26-104189.md) | [0.9](/filings/0000950170-25-069458.md) | [0.9](/filings/0000950170-25-106223.md) | [0.8](/filings/0001193125-25-273223.md) | [0.8 d](/filings/0001193125-26-104189.md) | [0.7](/filings/0001193125-26-215665.md) | [0.8](/filings/0001193125-26-341194.md) | [0.6](/filings/0001193125-25-273223.md) | [0.5 d](/filings/0001193125-26-104189.md) | [0.5](/filings/0001193125-26-215665.md) | [0.5](/filings/0001193125-26-341194.md) |
| Income tax | $m | [(1.7)](/filings/0000950170-24-122773.md) | [7.2 d](/filings/0001193125-26-104189.md) | [0.3](/filings/0000950170-25-069458.md) | [0.3](/filings/0000950170-25-106223.md) | [0.1](/filings/0001193125-25-273223.md) | [(2.3) d](/filings/0001193125-26-104189.md) | [1.0](/filings/0001193125-26-215665.md) | [2.5](/filings/0001193125-26-341194.md) | [4.7](/filings/0001193125-25-273223.md) | [2.2 d](/filings/0001193125-26-104189.md) | [1.7](/filings/0001193125-26-215665.md) | [3.3](/filings/0001193125-26-341194.md) |
| Net income | $m | [(1.3)](/filings/0000950170-24-122773.md) | [(25.5) d](/filings/0001193125-26-104189.md) | [(2.9)](/filings/0000950170-25-069458.md) | [(23.5)](/filings/0000950170-25-106223.md) | [(0.8)](/filings/0001193125-25-273223.md) | [(8.6) d](/filings/0001193125-26-104189.md) | [(6.7)](/filings/0001193125-26-215665.md) | [26.5](/filings/0001193125-26-341194.md) | [10.2](/filings/0001193125-25-273223.md) | [2.4 d](/filings/0001193125-26-104189.md) | [2.9](/filings/0001193125-26-215665.md) | [7.1](/filings/0001193125-26-341194.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0000950170-24-122773.md) | not reported | [(0.03)](/filings/0000950170-25-069458.md) | [(0.21)](/filings/0000950170-25-106223.md) | [(0.01)](/filings/0001193125-25-273223.md) | not reported | [(0.06)](/filings/0001193125-26-215665.md) | [0.24](/filings/0001193125-26-341194.md) | [0.08](/filings/0001193125-25-273223.md) | not reported | [0.02](/filings/0001193125-26-215665.md) | [0.06](/filings/0001193125-26-341194.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0000950170-24-122773.md) | not reported | [(0.03)](/filings/0000950170-25-069458.md) | [(0.21)](/filings/0000950170-25-106223.md) | [(0.01)](/filings/0001193125-25-273223.md) | not reported | [(0.06)](/filings/0001193125-26-215665.md) | [0.24](/filings/0001193125-26-341194.md) | [0.09](/filings/0001193125-25-273223.md) | not reported | [0.03](/filings/0001193125-26-215665.md) | [0.06](/filings/0001193125-26-341194.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [35.5](/filings/0000950170-23-060669.md) | [30.3](/filings/0000950170-25-038326.md) | [26.7](/filings/0000950170-24-055056.md) | [29.7](/filings/0000950170-24-093297.md) | [28.7](/filings/0000950170-24-122773.md) | [24.6](/filings/0001193125-26-104189.md) | [15.1](/filings/0000950170-25-069458.md) | [60.0](/filings/0000950170-25-106223.md) | [82.6](/filings/0001193125-25-273223.md) | [81.2](/filings/0001193125-26-341194.md) | [50.5](/filings/0001193125-26-215665.md) | [72.9](/filings/0001193125-26-341194.md) |
| Current assets | $m | [153](/filings/0000950170-23-060669.md) | [152](/filings/0000950170-25-038326.md) | [151](/filings/0000950170-24-055056.md) | [134](/filings/0000950170-24-093297.md) | [128](/filings/0000950170-24-122773.md) | [116](/filings/0001193125-26-104189.md) | [105](/filings/0000950170-25-069458.md) | [138](/filings/0000950170-25-106223.md) | [157](/filings/0001193125-25-273223.md) | [154](/filings/0001193125-26-341194.md) | [132](/filings/0001193125-26-215665.md) | [160](/filings/0001193125-26-341194.md) |
| Total assets | $m | [478](/filings/0000950170-23-060669.md) | [464](/filings/0000950170-25-038326.md) | [458](/filings/0000950170-24-055056.md) | [425](/filings/0000950170-24-093297.md) | [418](/filings/0000950170-24-122773.md) | [389](/filings/0001193125-26-104189.md) | [377](/filings/0000950170-25-069458.md) | [404](/filings/0000950170-25-106223.md) | [418](/filings/0001193125-25-273223.md) | [423](/filings/0001193125-26-341194.md) | [401](/filings/0001193125-26-215665.md) | [428](/filings/0001193125-26-341194.md) |
| Current liabilities | $m | [68.9](/filings/0000950170-23-060669.md) | [72.2](/filings/0000950170-25-038326.md) | [72.7](/filings/0000950170-24-055056.md) | [68.2](/filings/0000950170-24-093297.md) | [62.6](/filings/0000950170-24-122773.md) | [62.2](/filings/0001193125-26-104189.md) | [54.6](/filings/0000950170-25-069458.md) | [51.8](/filings/0000950170-25-106223.md) | [56.4](/filings/0001193125-25-273223.md) | [58.6](/filings/0001193125-26-341194.md) | [43.1](/filings/0001193125-26-215665.md) | [50.6](/filings/0001193125-26-341194.md) |
| Total liabilities | $m | [141](/filings/0000950170-23-060669.md) | [148](/filings/0000950170-25-038326.md) | [146](/filings/0000950170-24-055056.md) | [139](/filings/0000950170-24-093297.md) | [133](/filings/0000950170-24-122773.md) | [125](/filings/0001193125-26-104189.md) | [119](/filings/0000950170-25-069458.md) | [110](/filings/0000950170-25-106223.md) | [113](/filings/0001193125-25-273223.md) | [113](/filings/0001193125-26-341194.md) | [97.1](/filings/0001193125-26-215665.md) | [110](/filings/0001193125-26-341194.md) |
| Long-term debt | $m | [39.8](/filings/0000950170-23-060669.md) | [38.9](/filings/0000950170-25-038326.md) | [37.2](/filings/0000950170-24-055056.md) | [35.7](/filings/0000950170-24-093297.md) | [34.6](/filings/0000950170-24-122773.md) | [32.4](/filings/0001193125-26-104189.md) | [34.4](/filings/0000950170-25-069458.md) | [31.2](/filings/0000950170-25-106223.md) | [29.8](/filings/0001193125-25-273223.md) | [28.8](/filings/0001193125-26-341194.md) | [30.8](/filings/0001193125-26-215665.md) | [34.7](/filings/0001193125-26-341194.md) |
| Current portion of debt | $m | [9.3](/filings/0000950170-23-060669.md) | [9.1](/filings/0000950170-25-038326.md) | [8.9](/filings/0000950170-24-055056.md) | [8.7](/filings/0000950170-24-093297.md) | [8.6](/filings/0000950170-24-122773.md) | [8.1](/filings/0001193125-26-104189.md) | [4.8](/filings/0000950170-25-069458.md) | [7.9](/filings/0000950170-25-106223.md) | [4.8](/filings/0001193125-25-273223.md) | [4.9](/filings/0001193125-26-341194.md) | [5.0](/filings/0001193125-26-215665.md) | [5.2](/filings/0001193125-26-341194.md) |
| Shareholders' equity | $m | [320](/filings/0000950170-23-060669.md) | [300](/filings/0000950170-25-038326.md) | [296](/filings/0000950170-24-055056.md) | [275](/filings/0000950170-24-093297.md) | [274](/filings/0000950170-24-122773.md) | [254](/filings/0001193125-25-273223.md) | [248](/filings/0000950170-25-069458.md) | [284](/filings/0000950170-25-106223.md) | [295](/filings/0001193125-25-273223.md) | [300](/filings/0001193125-26-341194.md) | [294](/filings/0001193125-26-341194.md) | [312](/filings/0001193125-26-341194.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.1 d](/filings/0000950170-24-122773.md) | [(1.5) d](/filings/0000950170-25-038326.md) | [(0.1)](/filings/0000950170-25-069458.md) | [5.7 d](/filings/0000950170-24-093297.md) | [4.3 d](/filings/0000950170-24-122773.md) | [0.4 d](/filings/0000950170-25-038326.md) | [(6.4)](/filings/0000950170-25-069458.md) | [28.6 d](/filings/0001193125-26-341194.md) | [24.4 d](/filings/0001193125-25-273223.md) | [11.4 d](/filings/0001193125-26-104189.md) | [(16.8)](/filings/0001193125-26-215665.md) | [8.9 d](/filings/0001193125-26-341194.md) |
| Capital expenditure | $m | [1.8 d](/filings/0000950170-24-122773.md) | [(0.8) d](/filings/0001193125-26-104189.md) | [1.9](/filings/0000950170-25-069458.md) | [0.9 d](/filings/0000950170-25-106223.md) | [2.8 d](/filings/0001193125-25-273223.md) | [1.6 d](/filings/0001193125-26-104189.md) | [1.2](/filings/0001193125-26-215665.md) | [4.0 d](/filings/0001193125-26-341194.md) | [1.8 d](/filings/0001193125-25-273223.md) | [11.1 d](/filings/0001193125-26-104189.md) | [9.2](/filings/0001193125-26-215665.md) | [6.2 d](/filings/0001193125-26-341194.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-215665.md) | [0.0 d](/filings/0001193125-26-341194.md) | not reported | not reported | [6.4](/filings/0001193125-26-215665.md) | [0.4 d](/filings/0001193125-26-341194.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [88.7](/filings/0000950170-23-060669.md) | [104](/filings/0000950170-24-055056.md) | [110](/filings/0000950170-24-093297.md) | [110](/filings/0000950170-24-122773.md) | [110](/filings/0000950170-25-069458.md) | [111](/filings/0000950170-25-106223.md) | [112](/filings/0001193125-25-273223.md) | [112](/filings/0001193125-26-215665.md) | [113](/filings/0001193125-26-341194.md) | [121](/filings/0001193125-25-273223.md) | [127](/filings/0001193125-26-215665.md) | [125](/filings/0001193125-26-341194.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 122,286,297 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-341194.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.